Master regulators, Regulatory networks, And pathways of glioblastoma subtypes

Cancer Informatics

Volumn 13, Issue , 2014, Pages 33-44

  Bozdag, Serdar ^a,b   Li, Aiguo ^a   Baysan, Mehmet ^a,c   Fine, Howard A ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Classical; GBM; GBM subtypes; Gene regulatory networks; Glioblastoma multiforme; Master regulators; Mesenchymal; Neural; Pathways; Proneural

Indexed keywords

NEUROTRANSMITTER; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; COMPUTER PROGRAM; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETIC STABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MACHINE LEARNING; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MEDICAL INFORMATICS; PROMOTER REGION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TF GENE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION;

EID: 84907877985     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S14027     Document Type: Article

References (41)

1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93–108.
2. Adamson C, Kanu OO, Mehta AI, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18(8):1061–83.
3. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63(7):1602–7.
4. Liang Y, Diehn M, Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A. 2005;102(16):5814–9.
5. Mclendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–8.
6. Li A, Walling J, Ahn S, et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res. 2009;69(5):2091–9.
7. Verhaak RGW, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
8. Noushmehr H, Weisenberger DJ, Diefes K, et al. Identification of a cpg island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010;17(5):510–22.
9. Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483(7390):479–83.
10. Carro MS, Lim WK, Alvarez MJ, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279):318–25.
11. Bhat KPL, Salazar KL, Balasubramaniyan V, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25(24):2594–609.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol. 1995;57:289–300.
13. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.
14. Bozdag S, Li A, Wuchty S, Fine HA. FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics. 2010;26(14):1792–3.
15. Karolchik D, Baertsch R, Diekhans M, et al. The UCSC genome browser database. Nucleic Acids Res. 2003;31(1):51–4.
16. Guberman JM, Ai J, Arnaiz O, et al. BioMart central portal: an open database network for the biological community. Database (Oxford). 2011;2011:bar041.
17. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nat Rev Genet. 2009;10(4):252–63.
18. Kundaje A, Xin X, Lan C, et al. A predictive model of the oxygen and heme regulatory network in yeast. PLoS Comput Biol. 2008;4(11):e1000224.
19. Schmulevich I, Schwikowski B, Warner G, Ideker T. Integration of biological networks and gene expression data using cytoscape. Nat Protoc. 2007;2:2366–82.
20. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4(1):44–57.
21. Cooper LAD, Gutman DA, Chisolm C, et al. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol. 2012;180(5):2108–19.
22. Liu Y, Yan W, Zhang W, et al. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep. 2012;28(3):1013–21.
23. Haapa-Paananen S, Kiviluoto S, Waltari M, et al. HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation. Oncogene. 2012;31(10):1299–310.
24. Somasundaram K, Reddy SP, Vinnakota K, et al. Upregulation of ASCL1 and inhibition of notch signaling pathway characterize progressive astrocytoma. Oncogene. 2005;24(47):7073–83.
25. Guilhamon P, Eskandarpour M, Halai D, et al. Meta-analysis of idh-mutant cancers identifies EBF1 as an interaction partner for TET2. Nat Commun. 2013;4:2166.
26. Liao D. Emerging roles of the EBF family of transcription factors in tumor suppression. Mol Cancer Res. 2009;7(12):1893–901.
27. Held-Feindt J, Hattermann K, Knerlich-Lukoschus F, Mehdorn HM, Mentlein R. SP100 reduces malignancy of human glioma cells. Int J Oncol. 2011;38(4):1023–30.
28. Ladha J, Sinha S, Bhat V, Donakonda S, Rao SMR. Identification of genomic targets of transcription factor AEBP1 and its role in survival of glioma cells. Mol Cancer Res. 2012;10(8):1039–51.
29. Doucette T, Rao G, Rao A, et al. Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunol Res. 2013;1:112.
30. Noy P, Williams H, Sawasdichai A, Gaston K, Jayaraman PS. PRH/hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. Mol Cell Biol. 2010;30(9):2120–34.
31. Yeh WC, Shahinian A, Speiser D, et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 1997;7(5):715–25.
32. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic traf2-dependent pathway. Science. 1997;275(5297):200–3.
33. Martin KH, Slack JK, Boerner SA, Martin CC, Parsons JT. Integrin connections map: to infinity and beyond. Science. 2002;296(5573):1652–3.
34. Kenney AM, Cole MD, Rowitch DH. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development. 2003;130(1):15–28.
35. Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog. Neuron. 1999;22(1):103–14.
36. Schneider E, Bertron A-F, Dy M. Modulation of hematopoiesis through histamine receptor signaling. Front Biosci (Schol Ed). 2011;3:467–73.
37. Bardot V, Dutrillaux AM, Delattre JY, et al. Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations. Br J Cancer. 1994;70(2):212–18.
38. Cao S, Wang C, Zheng Q, et al. STAT5 regulates glioma cell invasion by pathways dependent and independent of STAT5 DNA binding. Neurosci Lett. 2011;487(2):228–33.
39. Samimi G, Ring BZ, Ross DT, et al. TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinoma. Cancer Epidemiol Biomarkers Prev. 2012;21(2):273–9.
40. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157–73.
41. Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia 2011, 59(8):1190–9.